相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging
Volkan Turan et al.
HUMAN REPRODUCTION UPDATE (2020)
Key steps for effective breast cancer prevention
Kara L. Britt et al.
NATURE REVIEWS CANCER (2020)
PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
Srilatha Simhadri et al.
ONCOGENE (2019)
PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper
Gabor Liposits et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Isabella Faraoni et al.
CANCERS (2018)
NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
TP53 Mutations in Breast and Ovarian Cancer
Laxmi Silwal-Pandit et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Breast Cancer Screening and Prevention
Ann B. Nattinger et al.
ANNALS OF INTERNAL MEDICINE (2016)
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer
Nadine Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
An assembly and alignment-free method of phylogeny reconstruction from next-generation sequencing data
Huan Fan et al.
BMC GENOMICS (2015)
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study
Inmaculada de Juan et al.
FAMILIAL CANCER (2015)
A mechanism for the suppression of homologous recombination in G1 cells
Alexandre Orthwein et al.
NATURE (2015)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Kyriaki Michailidou et al.
NATURE GENETICS (2015)
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers
Shoko Vos et al.
ONCOTARGET (2015)
BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks
Nicholas A. Willis et al.
NATURE (2014)
Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012
Puay Hoon Tan et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou et al.
NATURE GENETICS (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Performance comparison of benchtop high-throughput sequencing platforms
Nicholas J. Loman et al.
NATURE BIOTECHNOLOGY (2012)
Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology
Shane R. Stecklein et al.
TRANSLATIONAL RESEARCH (2012)
Field guide to next-generation DNA sequencers
Travis C. Glenn
MOLECULAR ECOLOGY RESOURCES (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Cloning and characterization of a new BRCA1 variant: A role for BRCT domains in apoptosis
Meijia Gu et al.
CANCER LETTERS (2010)
Detection of nonneutral substitution rates on mammalian phylogenies
Katherine S. Pollard et al.
GENOME RESEARCH (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Targeting homologous recombination repair defects in cancer
Bastiaan Evers et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
Sean V. Tavtigian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Palliative Care
Michael H. Levy et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Models of genetic susceptibility to breast cancer
A. C. Antoniou et al.
ONCOGENE (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)